Yoshitaka Seki

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada et al. · Investigational New Drugs · 2016 · 90 citations · Full text

Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess<i>EGFR</i>Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors

Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno et al. · The Oncologist · 2016 · 55 citations · Full text

Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study

Hajime Asahina, Hiroshi Nokihara, Noboru Yamamoto et al. · Investigational New Drugs · 2012 · 37 citations

Oncology, Dose-finding Phase, Metronomic Therapy +10

Pediatric Patient and Parental Anxiety and Impressions Related to Initial Gastrointestinal Endoscopy: A Japanese Multicenter Questionnaire Study

Shin‐ichiro Hagiwara, Yoshiko Nakayama, Manabu Tagawa et al. · Scientifica · 2015 · 30 citations · Full text

Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

Zenya Saito, Yugo Kaneko, Akira Kinoshita et al. · BMC Infectious Diseases · 2016 · 28 citations · Full text